| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |